The structure of adeno-associated virus serotype 3B (AAV-3B): insights into receptor binding and immune evasion.
Adeno-associated viruses (AAVs) are leading candidate vectors for human gene therapy. AAV serotypes have broad cellular tropism and use a variety of cellular receptors. AAV serotype 3 binds to heparan sulfate proteoglycan prior to cell entry and is serologically distinct from other serotypes. The capsid features that distinguish AAV-3B from other serotypes are poorly understood. The structure of AAV-3B has been determined to 2.6A resolution from twinned crystals of an infectious virus. The most distinctive structural features are located in regions implicated in receptor and antibody binding, providing insights into the cell entry mechanisms and antigenic nature of AAVs. We show that AAV-3B has a lower affinity for heparin than AAV-2, which can be rationalized by the distinct features of the AAV-3B capsid. The structure of AAV-3B provides an additional foundation for the future engineering of improved gene therapy vectors with modified receptor binding or antigenic characteristics.
Lerch
Thomas F
TF
Department of Biochemistry and Molecular Biology, School of Medicine, Oregon Health & Science University, Portland, OR 97239-3098, USA.
Xie
Qing
Q
Chapman
Michael S
MS
D002213:Capsid / Q000648:ultrastructure*; D018360:Crystallography, X-Ray; D000229:Dependovirus / Q000276:immunology / Q000502:physiology / Q000648:ultrastructure*; D006497:Heparan Sulfate / Q000378:metabolism; D006801:Humans; D057131:Immune Evasion; D008958:Models, Molecular; D020836:Protein Structure, Quaternary; D053585:Virus Attachment
D006497:Heparan Sulfate
Proc Natl Acad Sci U S A. 1988 May;85(10):3304-8
2835768
J Virol. 2006 Jan;80(2):821-34
16378984
Virology. 1993 Aug;195(2):745-56
8337843
Acta Crystallogr D Biol Crystallogr. 2002 Nov;58(Pt 11):1948-54
12393927
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2008 Nov 1;64(Pt 11):1074-8
18997346
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007 Dec 1;63(Pt 12):1073-6
18084098
J Virol. 2008 Feb;82(3):1399-406
18045941
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2256-68
15572779
Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3
15299374
J Virol. 2008 Jun;82(12):5887-911
18400866
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005 Oct 1;61(Pt 10):917-21
16511195
Cells Tissues Organs. 2004;177(3):139-50
15388988
Structure. 1998 Nov 15;6(11):1369-81
9817841
J Comput Chem. 2004 Oct;25(13):1605-12
15264254
J Virol Methods. 2004 Dec 1;122(1):17-27
15488616
Mol Ther. 2005 Oct;12(4):725-33
16169458
J Virol. 2006 Jul;80(14):7265-9
16809332
Virology. 1996 Jul 1;221(1):208-17
8661429
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Jul 1;65(Pt 7):715-8
19574648
Nat Med. 1999 Jan;5(1):78-82
9883843
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W665-7
15215472
Arch Virol. 2008;153(11):2107-10
18937030
Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905-21
9757107
Virology. 2009 Mar 15;385(2):434-43
19144372
J Virol. 1998 Feb;72(2):1438-45
9445046
J Virol. 2006 Sep;80(18):9093-103
16940521
J Virol. 1998 Jan;72(1):309-19
9420229
J Virol. 2006 Oct;80(19):9831-6
16973587
Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10405-10
12136130
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2006 Dec 1;62(Pt 12):1271-4
17142915
Nat Med. 1999 Jan;5(1):71-7
9883842
J Virol. 1997 Aug;71(8):5932-41
9223483
Gene Ther. 2008 Jan;15(1):12-7
17943147
Acta Crystallogr A. 1991 Mar 1;47 ( Pt 2):110-9
2025413
J Virol. 2001 Aug;75(15):6884-93
11435568
J Struct Biol. 2009 Mar;165(3):146-56
19121398
J Virol. 2004 Jun;78(12):6381-8
15163731
Nat Biotechnol. 2010 Jan;28(1):79-82
20037580
J Virol. 2007 Nov;81(22):12260-71
17728238
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10037-41
11517324
Methods Enzymol. 1997;276:594-611
9048382
J Virol. 2003 Oct;77(20):11072-81
14512555
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
15572765
Acta Crystallogr D Biol Crystallogr. 2006 Mar;62(Pt 3):227-38
16510969
J Virol. 2004 Apr;78(7):3361-71
15016858
J Virol. 2000 Oct;74(19):9281-93
10982375
Virology. 1996 Mar 1;217(1):124-30
8599196
J Virol. 2006 Sep;80(18):8961-9
16940508
Structure. 1995 Feb 15;3(2):151-62
7735832
Hum Gene Ther. 2006 Jan;17(1):10-9
16409121
J Virol. 2002 Jan;76(2):791-801
11752169
J Virol. 2003 Jun;77(12):6995-7006
12768018
J Gen Virol. 2000 Aug;81(Pt 8):2077-2084
10900047
Virology. 1988 Jun;164(2):373-82
2835857
J Virol. 2006 Dec;80(23):11556-70
16971437
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Feb 1;65(Pt 2):177-83
19194015
Arch Virol. 2006 Mar;151(3):617-23
16195782